Ergoteles’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Ergoteles’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-43,200	Closed	-$876K	–	1988
2022 Q4	$876K	Buy	+43,200	New	+$662K	0.03%	503

Ergoteles's OPNT Position: Q1 2023 in Review

Ergoteles sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 43,200 shares — an estimated $876K sold.

Ergoteles first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $876K in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

Ergoteles reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 43,200 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $876K.
Ergoteles first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Ergoteles's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $876K in Q4 2022.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.